Small interfering RNA (siRNA) inhibited human liver cancer cell line SMMC7721 proliferation and tumorigenesis

Hepato-Gastroenterology

Volumn 54, Issue 78, 2007, Pages 1731-1735

  Dong Dong, Lu ^a  

^a TONGJI UNIVERSITY   (China)

Author keywords

AKR1C2 gene; Liver cancer; RNAi; SMMC7721; Tumorigenesis in vivo and vitro

Indexed keywords

CELL DNA; SMALL INTERFERING RNA;

ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; COLONY FORMATION; CONTROLLED STUDY; FLOW CYTOMETRY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIVER CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTINEOPLASTIC AGENTS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; DRUG SCREENING ASSAYS, ANTITUMOR; FLOW CYTOMETRY; GENETIC VECTORS; HUMANS; LIVER NEOPLASMS; MEDICAL ONCOLOGY; RNA INTERFERENCE; RNA, SMALL INTERFERING; TIME FACTORS; TRANSFECTION;

EID: 35949000503     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Hara A: Home Supins. mRNA for DD2/bile acid-bind protein/AKR1C2/32-hydroxysteroid dehydrogenase type. Clin Biochem 2001; 32(6):467-472.
2. Bauman DR, Steckelbroeck S, Penning TM: The roles of aldo-keto reductases in steroid hormone action. Drug News Perspect 2004; 17(9):563-578.
3. Blouin K, Blanchette S, Richard C, Dupont P, Luu-The V, Tchernof A: Expression and activity of steroid aldoketoreductases 1C in omental adipose tissue are positive correlates of adiposity in women. Am J Physiol Endocrinol Metab 2005; 288(2):E398-404.
4. Steckelbroeck S, Jin Y, Oyesanmi B, Kloosterboer HJ, Penning TM: Tibolone is metabolized by the 3alpha/3beta-hydroxysteroid dehydrogenase activities of the four human isozymes of the aldo-keto reductase 1C subfamily: inversion of stereospecificity with a delta5(10)-3-ketosteroid. Mol Pharmacol 2004; 66(6):1702-1711.
5. Rizner TL, Lin HK, Penning TM: Role of human type 3 3alpha-hydroxysteroid dehydrogenase (AKR1C2) in androgen metabolism of prostate cancer cells. Chem Biol Interact 2003; 1:143-144.
6. Lewis MJ, Wiebe JP, Heathcote JG: Expression of progesterone metabolizing enzyme genes (AKR1C1, AKR1C2, AKR1C3, SRD5A1, SRD5A2) is altered in human breast carcinoma. BMC Cancer 2004; 4(1):27.
7. Dong-Dong L, Zhang XZ, Cao XR: The effect of AKR1C2 gene on hepatocarcinogenesis and its abnormal expression in hepatocellular carcinoma from Qidong, China, a liver cancer high risk area. Prog Biochem Biophys 2003; 30(6):906-928.
8. Dong-Dong L: Growth factor NUN increased AKR1C2 expression by activated CDK2 related RB signal transduction pathway in human liver cancer cell line. Hepatogastroenterology 2005; 52(62):567-570.
9. Elbashir SM, Harborth J, Lendeckal W, et al: Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001; 411:494-498.
10. Penning TM, Jin Y, Steckelbroeck S, Lanisnik Rizner T, Lewis M: Structure-function of human 3 alpha-hydroxysteroid dehydrogenases: genes and proteins. Mol Cell Endocrinol 2004; 215(1-2):63-72.
11. Penning TM, Jin Y, Heredia VV, Lewis M: Structure-function relationships in 3alpha-hydroxysteroid dehydrogenases: a comparison of the rat and human isoforms. J Steroid Biochem Mol Biol 2003; 85(2-5):247-255.
12. Trauger JW, Jiang A, Stearns BA, LoGrasso PV: Kinetics of allopregnanolone formation catalyzed by human 3 alpha-hydroxysteroid dehydrogenase type III (AKR1C2). Biochemistry 2002; 41(45):13451-13459.
13. Rizner TL, Lin HK, Peehl DM, Steckelbroeck S, Bauman DR, Penning TM: Human type 3 3alpha-hydroxysteroid dehydrogenase (aldo-keto reductase 1C2) and androgen metabolism in prostate cells. Endocrinology 2003; 144(7):2922-2932.
14. Steckelbroeck S, Jin Y, Oyesanmi B, Kloosterboer HJ, Penning TM: Tibolone is metabolized by the 3alpha/3beta-hydroxysteroid dehydrogenase activities of the four human isozymes of the aldo-keto reductase 1C subfamily: inversion of stereospecificity with a delta5(10)-3-ketosteroid. Mol Pharmacol 2004; 66(6):1702-1711.